Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer | Zendy

Limei Liu | Zendy; Jiaomin Yang | Zendy; Chao Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer

Author(s) -

Limei Liu,

Jiaomin Yang,

Chao Wang

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20200764

Subject(s) - breast cancer , cancer , gene , genetics , solute carrier family , biology , oncology , computational biology , medicine , transporter

Breast cancer (BC) is the most common malignancy in females and remains a main cause of cancer-associated death worldwide. The solute carrier (SLC) groups of membrane transport proteins, which control the influx of zinc, participate in ranging of physiological processes and may provide novel therapeutic targets of cancers. However, the prognostic values of individual SLC family 39 (SLC39A) genes in patients with BC are not clarified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research